MedicationsMyBlueDotsStudy finds no elevated risk of thyroid cancer among GLP1-RA users MyBlueDots4 months ago01 mins A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased risk of thyroid cancer. Go to Sourcehttps://medicalxpress.com/rss-feed/ Post navigation Previous: Survey shows previous experience affects family planning decisions of people with hereditary dementiaNext: Framework outlines steps for achieving health equity in stroke care
An overlooked cell type orchestrates brain rewiring during states of heightened attention MyBlueDots3 days ago 0
Violence between parents or in the community increases risk of child punishment MyBlueDots3 days ago 0
Genome mapping of Brazil’s diverse population uncovers new variants linked to health MyBlueDots3 days ago 0